Multiple primary tumors following stage II and III rectal cancer in patients receiving radiotherapy, 1998–2010
- First Online:
- 243 Downloads
This report investigated the impact of radiation therapy among stage II/III rectal cancer patients who were resected for cure and then developed second primary cancer.
The analysis included patients diagnosed with rectal cancer from 1992 to 2010 and who were registered in the National Cancer Institute’s Surveillance, Epidemiology and End Results database. Standardized incidence ratios assessed the location of second primary cancers by the receipt and sequence of radiation therapy. A Cox proportional hazards model examined the predictors for patients who developed second primary cancers.
The hazard ratio for developing any type of second primary was 12 % higher in patients receiving preoperative radiotherapy, Hazard Ratio and 95 % confidence interval, HR 95 % CI 1.12 (1.0, 1.2), and 33 % lower for patients receiving postoperative radiotherapy, HR 95 % CI 0.75 (0.7, 0.8), relative to patients who did not receive radiation therapy. The location of the second cancer varied by both the receipt and sequence of radiation therapy. Secondary rectal cancers were reduced 170 % after postoperative radiation and 103 % after preoperative radiation, compared to the non-receipt of radiation therapy. The impact of radiation therapy on secondary colon cancers was not as marked. Rectal cancer patients undergoing radiation therapy are at a higher risk of thyroid cancers and leukemia, but males have a lower risk of prostate cancer.
While preoperative radiation therapy is advantageous for reducing rectal cancer recurrence, this study identifies advantages of postoperative radiation for reducing second primary cancers. This research will help improve recommendations for postdiagnosis surveillance in patients with rectal cancer.
KeywordsRectal cancer Second primary cancer Radiation therapy National Cancer Institute SEER
- American Cancer Society (2013) Cancer facts & figures 2013. American Cancer Society, AtlantaGoogle Scholar
- Benson AB III, Bekaii-Saab T, Chan E et al (2012) Rectal cancer. J Natl Compr Cancer Netw 10:1528–1564Google Scholar
- Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al (2004) Sphincter preservation following pre-operative radiotherapy for rectal cancer: report of a randomized trial comparing short-term radiotherapy vs conventionally fractionated radiochemotherapy. Radiother Oncol 72:15–24Google Scholar
- Edge SB, Byrd DR, Compton CC et al (eds) (2009) American joint committee on cancer staging manual, 7th edn. Springer, New YorkGoogle Scholar
- Fast stats: an interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute. http://seer.cancer.gov/faststats. Accessed 6 Dec 2013
- Hemminki K, Li X, Dong C (2001) Second primary cancers after sporadic and familial colorectal cancer. Cancer Epidemiol Biomark Prev 10:793–798Google Scholar
- Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2013) SEER cancer statistics review, 1975–2010, National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975_2010/. Accessed 2 Dec 2013
- Johnson C, Peace S, Adamo P, Fritz A, Percy-Laurry A, Edwards BK (2007) The 2007 multiple primary and histology coding rules. National Cancer Institute, BethesdaGoogle Scholar
- Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol 156:471–482PubMedCrossRefGoogle Scholar
- National Cancer Institute: PDQ® Colon Cancer Treatment (2013a) Bethesda, MD: National Cancer Institute. http://cancer.gov/cancertopics/pdq/treatment/colon/HealthProfessional. Accessed 6 Dec 2013
- National Cancer Institute: PDQ® Rectal Cancer Treatment (2013b) Bethesda, MD: National Cancer Institute. http://cancer.gov/cancertopics/pdq/treatment/colon/HealthProfessional. Accessed 6 Dec 2013
- National Comprehensive Cancer Network Practice Guidelines in Oncology 2010 (2011) www.nccn.org Accessed 6 Dec 2013
- Raj KP, Taylor TH, Wray C, Stamos MJ, Zell JA (2011) Risk of second primary colorectal cancer among colorectal cancer cases: a population-based analysis. J Carcinog 17(10):6Google Scholar
- Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence—SEER 9 Regs Research Data, November 2012 submission, Vintage 2009 Populations (1992–2010) <Katrina/Rita Population Adjustment> Linked to County Attributes—Total US, 1969-2010 Counties. Bethesda, MD: National Cancer Institute, Surveillance Research Program, Cancer Statistics Branch; released April 2012, based on the November 2012 submission. www.seer.cancer.gov. Accessed 7 Dec 2013